Clinical Trial Update: Use of RAD001 as Monotherapy in the Treatment of Neurofibromatosis 1 Related Internal Plexiform Neurofibromas [Phase 2]

View source ↗

Summary

A Phase 2 trial of RAD001 (everolimus) as monotherapy for Neurofibromatosis type 1-related internal plexiform neurofibromas has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type
• Plexiform Neurofibroma

Drugs mentioned

• RAD001 (Everolimus) (everolimus)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Neurofibromatosis Type 1, Plexiform Neurofibroma | Phase 2 | Status: COMPLETED